Research & Development in the
Canton of Basel-Country

Urs Endress Stiftung

Since 2015 · 11–20 empl.

Urs Endress Stiftung supports research and development projects in civil mine detection, including the FindMine project which uses unmanned air systems (UAS/drones) and advanced measurement techniques to locate mines, duds and similar munitions. The foundation also established the Mine Detection Symposium as an interdisciplinary platform for experts in the field.

Aquametro Oil & Marine AG

Since 2017 · 21–50 empl.

The company is active in the shipping industry and offers products and services tailored to the needs of the shipping industry. In particular, the company focuses on the development and distribution of solutions for the oil and shipping industry, with a focus on environmental protection and sustainability ("Green Shipping").

smv3.ch GmbH

Since 2017 · 11–20 empl.

The core activity of smv3.ch is to provide services in the field of bioanalytical mass spectrometry for pharmaceutical research and development. This includes the development and application of mass spectrometric methods for the analysis of biomarkers, metabolites and other substances in various biological matrices. The company also offers consulting services for pharmaceutical research and development and facilitates access to external laboratories.

N.E.T. - Network.Enable.Think. GmbH

Since 2017 · 1–10 empl.

N.E.T. - Network.Enable.Think. GmbH provides consulting and implementation services to support clients in developing and realizing ideas. Services include conception and project management, workshops, surveys and interviews, analysis and coordination, organising cross‑industry networking events, and designing workspaces and technology‑oriented solution options.

Gigabases Switzerland AG

Since 2018 · 1–10 empl.

Gigabases Switzerland AG operates a web-based platform for 3D protein design and ordering sequence-verified expression plasmids. The platform provides a database of over 214 million protein 3D structures, tools to modify proteins at the amino-acid level, and algorithms that translate designs into ready-to-order plasmids for mammalian, viral, or bacterial expression.

OncoGenomX AG

Since 2019 · 1–10 empl.

OncoGenomX AG provides PredictionStar, a therapy decision-support tool for breast cancer that analyzes tumor-specific genomic, biological, pathological and clinical data to inform treatment composition. The point-of-care platform applies patented algorithms and machine-learning–assisted drug–tumor matching, delivers analysis reports within the hospital IT environment without additional invasive procedures, and is designed for routine clinical use.

Herbavita-Swiss GmbH

Since 2021 · 11–20 empl.

The core activity of Herbavita-Swiss GmbH is the cultivation, processing, production and research of hemp products, particularly in the field of cannabis products. The company also offers laboratory analysis and consulting services to ensure the quality and safety of hemp products. This includes analysis of contaminants, pesticide residues, mycotoxins and other parameters to ensure compliance with legal limit values.

PK-Insights GmbH

Since 2011 · 1–10 empl.

DeltaMem AG

Since 2016 · 11–20 empl.·5.0(2)

The core activity of DeltaMem AG is the development and supply of membrane technologies and plants for the dehydration of organic solvents in the pharmaceutical, biotechnology, bioenergy and fine chemical industries. In particular, the company focuses on pervaporation and cross-flow filtration to clean and concentrate solvents. DeltaMem AG develops and supplies customized plants and solutions for industry, including membrane modules, process engineering and optimization.

Spengler Electronic AG

Since 1977 · 11–20 empl.·5.0(4)

The core activity of Spengler Electronic AG is the development, production and distribution of electrostatic systems and solutions for the printing industry and other sectors. In particular, the company focuses on the areas of discharging, charging, ESA (Electrostatic Printing Aid Systems), web handling, dust removal and high-voltage measuring devices.

Perseo pharma AG

Since 2019 · 11–20 empl.

The core activity of Perseo Pharma AG is the development of enzyme replacement therapies for the treatment of metabolic diseases, in particular for rare diseases such as exocrine pancreatic insufficiency, congenital sucrase-isomaltase deficiency and maple syrup urine disease. The company develops innovative therapies based on the enzzen platform technology and focuses on the clinical development of active ingredients for the treatment of these diseases.

Stiftung Forschung Klinik Arlesheim

Since 2023 · 21–50 empl.·3.9(21)

Stiftung Forschung Klinik Arlesheim funds and supports clinical research projects at Klinik Arlesheim, providing grants and accepting donations to finance research activities.

InCephalo AG

Since 2021 · 1–10 empl.

The core activity of InCephalo Therapeutics is the development and research of local therapies for neurological diseases, particularly brain cancer. The company focuses on the development of biological drugs specifically designed for local application in the central nervous system (CNS) to minimize side effects and maximize efficacy. The proprietary Compartment Lock technology (C-Lock) enables the local retention of biological drugs in the CNS, prolonging their effect while minimizing systemic exposure.

Chemoforma AG

Since 1966 · 1–10 empl.·5.0(1)

Chemoforma AG develops and manufactures natural complementary feed products for livestock and companion animals and supplies products for aquaculture. The company is GMP+ and ISO 9001 certified and markets product lines such as ASCOGEN®, VANNAGEN®, BIORACING® and ASCOSAN®.

Bright Peak Therapeutics AG

Since 2017 · 51–100 empl.·5.0(1)

The core activity of Bright Peak Therapeutics is the development of cancer medications, particularly in the field of immuno-oncology, antibody-drug conjugates (ADCs) and biologics.

BioConcept AG

Since 1988 · 1–10 empl.·3.4(7)

The core activity of BioConcept Ltd. is the manufacture and distribution of products and services in the field of biotechnology and life sciences, particularly in the areas of cell culture, molecular biology, immunology and microbiology. This includes the development and production of customer-specific cell culture media, enzymes, antibodies, cell lines, tissue samples and other biological products, as well as the provision of services such as pipette and cycle maintenance.

AnaPath Services GmbH

Since 2012 · 11–20 empl.·5.0(3)

The core activity of AnaPath Services is the provision of histopathological services, particularly in the fields of toxicology and molecular pathology. This includes, among others: Histopathology, Molecular Pathology, Special technologies such as Electron Microscopy, Confocal Microscopy and Hyperspectral Microscopy, Study Management, Necropsy, and Histotechnology. The company positions itself as a contract laboratory and offers its services primarily to the pharmaceutical industry.

Integrative Taxonomy Lab GmbH

Since 2020 · 1–10 empl.

The core activity of ITaxLab GmbH encompasses the application and development of methods in integrative taxonomy, molecular biology, and ecology, particularly in the areas of: Applied Ecology, Integrative Taxonomy, Molecular Biology, Aquatic Ecology, Laboratory Management, Curation of Scientific Collections, Data Analysis, Bioinformatics, and GIS. The company offers services such as CO1 barcoding, multi-marker approaches, non-destructive DNA extraction, fieldwork, population genetics, habitat connectivity, habitat fragmentation, isolation, and knowledge transfer in these areas.

Alltimm GmbH

Since 2020 · 1–10 empl.

The core activity of Alltimm GmbH is the consulting of pharmaceutical startups in the development and production of innovative medicines, particularly in the CMC (Chemistry-Manufacturing-Controls) area.

Raylution AG

Since 2022 · 1–10 empl.

The core activity of Raylution AG is the development and/or provision of dermatological laser treatments.

TMR Triangle Micro Research AG

Since 1991 · 11–20 empl.·4.0(3)

The core activity of Triangle Micro Research AG is the development and provision of software solutions for the healthcare industry in Switzerland, particularly in the areas of: * Medical practice software (WinMed) * Middleware for medical tariffs and communication standards (Sumex1) * Form system for medical forms (medForms.ch) * Routing system for data exchange in healthcare (medSRS) The company develops and operates these solutions to reduce administrative burdens in healthcare, facilitate electronic communication, and improve the quality of medical care.

DMS Consulting GmbH

Since 2022 · 1–10 empl.

The core activity of VAKUMIN GmbH is the development, manufacture and marketing of high-quality cookware, in particular vacuum cooking pots, which enable energy savings and sustainable kitchen practices through their innovative technology.

Phialogics AG

Since 2022 · 1–10 empl.

Green Zero GmbH

Since 2025 · 1–10 empl.

Green Zero GmbH supports companies, organisations and municipalities with climate strategies, life cycle assessments, emissions reduction and compensation solutions. The company also offers environmental and sustainability certificates as well as its own renaturation areas for offsetting measures.

Labor-Innovation GmbH

Since 2005 · 1–10 empl.·5.0(1)

The core activity of Labor-Innovation GmbH is the development and realization of individual laboratory projects, the manufacture of modular laboratory workstations, prototypes and special solutions, as well as the provision of technical laboratory equipment and services such as qualification and consulting in the field of laboratory equipment.

INNOSIAMO AG

Since 2024 · 1–10 empl.

INNOSIAMO AG helps startups accelerate innovation in healthcare and create sustainable value through collaborations. The company focuses on supporting innovation projects with impact in the healthcare sector.

Crystallise! AG

Since 2017 · 1–10 empl.·4.0(1)

The core activity of Crystallise! AG is the crystallization of liquids and the analysis of crystals using X-ray and electron diffraction (micro-ED). The company provides services in the fields of crystallization, structure elucidation and identification of molecules, particularly for the pharmaceutical, chemical and agro-industry. It supports customers in the crystallization of active pharmaceutical ingredients (APIs), co-crystals/salts, polymorphic forms, natural products and other small molecules.

Monix Health AG

Since 2025 · 1–10 empl.

Monix Health AG develops a real-time hormone monitoring platform for women that combines a non-invasive wearable biosensor patch with an AI-powered app. The technology continuously detects LH and progesterone, transmits data to devices and clinicians, and is intended to support clinical timing decisions such as during IVF while reducing repeated blood draws.

Nanolynx Biologics AG

Since 2025 · 1–10 empl.

Nanolynx Biologics AG develops conditionally active nanobody-drug conjugates (CA-NDCs) for hard-to-treat solid tumors. The company uses an AI-enabled discovery platform and focuses on tumor-selective biologics for oncology targets such as CD70, CD142 and Nectin-4.

Gubra GmbH

Since 2026 · 1–10 empl.

Gubra GmbH is a biotechnology company operating through Biotech, CRO services and Ventures. It develops peptide-based drug candidates and provides preclinical research and development services across areas such as obesity, liver, kidney, lung and metabolic diseases.

HEMEX (Switzerland) AG

Since 2026 · 1–10 empl.

HEMEX (Switzerland) AG is a CRDMO providing integrated clinical research, development and manufacturing services for pharma, biotech and medtech projects. The company supports programs from early development through commercial-scale manufacturing and also covers regulatory affairs, biostatistics, data management and medical writing.

GlioCART GmbH

Since 2025 · 1–10 empl.

GlioCART GmbH develops a dual-action CAR-T therapy for glioblastoma. The company focuses on directly attacking tumor cells while also reprogramming the immunosuppressive tumor microenvironment.

Sugar Energy Swiss GmbH

Since 2025 · 1–10 empl.

Sugar Energy Swiss GmbH provides market development, sales and after‑sales services for bio‑based materials and downstream furan derivatives. Its product range includes 5‑HMF, FDCA, PEF and other furan‑based intermediates and products for use in pharmaceuticals, fine chemicals, packaging and feed additives.

Swiss Biome Institute GmbH

Since 2025 · 1–10 empl.

Swiss Biome Institute GmbH provides microbiome analysis to support clinical trials in functional foods, biotherapeutics and microbiota research. The institute performs advanced omics analyses (genomics, transcriptomics, proteomics, metabolomics), supports product efficacy validation and R&D project planning and implementation including computational analysis, and conducts epigenetic and mitochondrial research related to longevity using AI and in vivo studies.

Cancentus GmbH

Since 2026 · 1–10 empl.

IFE Industrielle Forschung und Entwicklung GmbH

Since 1995 · 1–10 empl.

IFE Industrielle Forschung und Entwicklung GmbH develops and delivers customer-specified, marketable technical products. The company operates across disciplines including optics and optical metrology, mathematics, mechanics, electronics and software, providing housing design, algorithm development, porting, testing and system integration for applications such as medical technology, bioanalysis and testing systems.

Medcontrol AG

Since 2001 · 1–10 empl.

The core activity of Medcontrol AG is the application of machine learning in medicine, particularly in physiotherapy.

Preclin Consulting GmbH

Since 2007 · 1–10 empl.

Preclin Consulting GmbH is a consultancy for toxicology, pathology and non‑clinical safety assessment. Services include preclinical development planning, design and monitoring of toxicology studies (genetic toxicology, safety pharmacology, reproductive and juvenile studies), pathology peer review and report assessment, calculation of human safety factors, and support for non‑clinical regulatory dossiers (e.g. IB, IMPD, CTD sections).